Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/4645
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKarabulut, Nevzat-
dc.contributor.authorElmas, N.-
dc.date.accessioned2019-08-16T11:35:51Z
dc.date.available2019-08-16T11:35:51Z
dc.date.issued2006-
dc.identifier.issn1305-3825-
dc.identifier.urihttps://hdl.handle.net/11499/4645-
dc.description.abstractSeveral categories of contrast agents with different biodistributions are currently available for magnetic resonance imaging of the liver. They improve lesion detection and characterization by increasing lesion-liver contrast. These agents include nonspecific extra-cellular gadolinium chelates, reticuloendothelial system-specific iron oxides, hepatocyte-selective agents, and combined perfusion and hepatocyte-selective agents. This article describes the currently used contrast agents in magnetic resonance imaging of the liver, summarizes their mechanisms of action, biodistributions, and safety profiles. Additionally, it reviews their main clinical indications, administration and imaging techniques, and the appearances of common hepatic lesions in contrast-enhanced studies. © Turkish Society of Radiology 2006.en_US
dc.language.isoenen_US
dc.relation.ispartofDiagnostic and Interventional Radiologyen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectContrast mediaen_US
dc.subjectGadoliniumen_US
dc.subjectLiver neoplasmsen_US
dc.subjectMagnetic resonance imagingen_US
dc.subjectcontrast mediumen_US
dc.subjectechovisten_US
dc.subjectgadobenate dimeglumineen_US
dc.subjectgadobenic aciden_US
dc.subjectgadobutrolen_US
dc.subjectgadodiamideen_US
dc.subjectgadolinium chelateen_US
dc.subjectgadolinium pentetateen_US
dc.subjectgadoterate meglumineen_US
dc.subjectgadoteridolen_US
dc.subjectgadoxetic aciden_US
dc.subjectiron oxideen_US
dc.subjectmangafodipiren_US
dc.subjectsuperparamagnetic iron oxideen_US
dc.subjectultrasmall superparamagnetic iron oxideen_US
dc.subjectarticleen_US
dc.subjectbackacheen_US
dc.subjectclinical trialen_US
dc.subjectcontrast enhancementen_US
dc.subjectdrug classificationen_US
dc.subjectdrug clearanceen_US
dc.subjectdrug distributionen_US
dc.subjectdrug eliminationen_US
dc.subjectdrug excretionen_US
dc.subjectdrug half lifeen_US
dc.subjectdrug indicationen_US
dc.subjectdrug mechanismen_US
dc.subjectdrug safetyen_US
dc.subjectdrug selectivityen_US
dc.subjectdyspneaen_US
dc.subjectflushingen_US
dc.subjecthepatographyen_US
dc.subjecthumanen_US
dc.subjectLD 50en_US
dc.subjectliver cellen_US
dc.subjectliver perfusionen_US
dc.subjectnauseaen_US
dc.subjectnonhumanen_US
dc.subjectnuclear magnetic resonance imagingen_US
dc.subjectosmolalityen_US
dc.subjectparticle sizeen_US
dc.subjectradiological proceduresen_US
dc.subjectreticuloendothelial systemen_US
dc.subjectskin manifestationen_US
dc.subjectContrast Mediaen_US
dc.subjectHumansen_US
dc.subjectLiver Diseasesen_US
dc.subjectLiver Neoplasmsen_US
dc.subjectMagnetic Resonance Imagingen_US
dc.titleContrast agents used in MR imaging of the liveren_US
dc.typeArticleen_US
dc.identifier.volume12en_US
dc.identifier.issue1en_US
dc.identifier.startpage22
dc.identifier.startpage22en_US
dc.identifier.endpage30en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopus2-s2.0-33644899677en_US
dc.identifier.scopusqualityQ3-
dc.ownerPamukkale_University-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeArticle-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:Tıp Fakültesi Koleksiyonu
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

40
checked on Dec 14, 2024

Page view(s)

56
checked on Aug 24, 2024

Google ScholarTM

Check





Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.